Pneumovax® 23 is an advanced, 23-valent pneumococcal polysaccharide vaccine manufactured by MSD to protect against invasive pneumococcal infections. Formulated as a single-dose 0.5mL solution in a pre-filled syringe with an attached needle, it contains purified capsular polysaccharides from 23 different serotypes of Streptococcus pneumoniae. This wide-ranging composition provides comprehensive coverage against the strains most frequently responsible for serious illnesses like bacteremic pneumonia, meningitis, and sepsis. Administered either intramuscularly or subcutaneously, it is a clinical cornerstone for enhancing immune defenses in elderly adults, immunocompromised individuals, and those with chronic medical conditions.